MAD2L1 and cancer: Lck-Cre::Mad2l1f/f::Trp53+/+ mice did not experience malignancies within the first year of life (Figure 1D) and adult T cells from these animals developed normally, suggesting that T cells are tolerant of Mad2l1 loss.